Idogen AB (OSTO:IDOGEN) Total Receivables: kr2.15 Mil (As of Mar. 2023)


OSTO:IDOGEN Idogen AB OSTO:IDOGEN
21 GF Score
Price kr0.12
View Full Analysis

What is Idogen AB Total Receivables?

Idogen AB OSTO:IDOGEN 21 Total Receivables is kr2.15 Mil as of Mar. 2023. GuruFocus rates OSTO:IDOGEN with a GF Score™ of 21/100.

Idogen AB's Total Receivables for the quarter that ended in Mar. 2023 was kr2.15 Mil.

Idogen AB Total Receivables Historical Data

* Premium members only.

The historical data trend for Idogen AB's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Idogen AB Total Receivables Chart

Idogen AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Receivables
Get a 7-Day Free Trial Premium Member Only 1.35 1.74 1.68 6.30 3.69

Idogen AB Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.50 6.78 3.09 3.69 2.15
OSTO:IDOGEN
21GF Score
Idogen AB OSTO:IDOGEN
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Idogen AB Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of kr2.15 Mil mean?
Idogen AB (OSTO:IDOGEN) has a Total Receivables of kr2.15 Mil as of Mar. 2023. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Idogen AB and its competitors.
Is Idogen AB's Total Receivables too high?
Idogen AB's current Total Receivables is kr2.15 Mil. Overall, Idogen AB has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Idogen AB's Total Receivables compare to REGN and VRTX?
Idogen AB's Total Receivables of kr2.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Idogen AB and its competitors. Idogen AB's current Total Receivables is kr2.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Idogen AB stock overvalued right now?
Idogen AB (OSTO:IDOGEN) has a current Total Receivables of kr2.15 Mil. The current Total Receivables is kr2.15 Mil. Idogen AB's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Idogen AB (OSTO:IDOGEN), the current Total Receivables is kr2.15 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Idogen AB Business Description

Address Medicon Village, Scheelevagen 2, Lund, SWE, 223 81
Idogen AB is a Swedish biotech company engaged in developing tolerogenic cell therapies to prevent biological drugs, transplanted or body cells or tissues from being attacked by the patient's immune system. Its product IDO 8, treats patients with severe hemorrhagic disease.
21GF Score

Get the complete analysis for OSTO:IDOGEN

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.12
Price